Knockdown of SOD1 sensitizes the CD34+ CML cells to imatinib therapy

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

Brian Druker, Shu Tamura, Elisabeth Buchdunger et al. · Nature Medicine · 1996 · 3.7K citations

Life Sciences, Molecular Biology, Oncology +13

FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress

Zuzana Tóthová, Ramya Kollipara, Brian J.P. Huntly et al. · Cell · 2007 · 1.5K citations · Full text

Life Sciences, Cell Biology, Hematology +16

The Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the <i>bcr</i> / <i>abl</i> Hybrid Gene

Yinon Ben‐Neriah, George Q. Daley, Anne‐Marie Mes‐Masson et al. · Science · 1986 · 825 citations

Life Sciences, Molecular Biology, Oncology +9

TGF-β–FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia

Kazuhito Naka, Takayuki Hoshii, Teruyuki Muraguchi et al. · Nature · 2010 · 576 citations · Full text

Medicine, Cell Biology, Hematology +16

BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death [published erratum appears in Blood 1994 Jun 15;83(12):3835]

A McGahon, Reid P. Bissonnette, Martin Schmitt et al. · Blood · 1994 · 486 citations · Full text

Medicine, Hematology, Oncology +13